CXCR4 and neoplasm: Likewise, blocking CXCL12/CXCR4 using AMD3100 significantly inhibited tumor growth and metastasis, and the combination of AMD3100 and anti-PD-1 further reduced tumor growth and metastasis (Fig. 6a and b).